Harrow Health (HROW) Misses Q3 EPS by 7c
Tweet
Share
E-mailGet Alerts HROW Hot Sheet
Join SI Premium – FREE
Harrow Health (NASDAQ: HROW) reported Q3 EPS of ($0.12), $0.07 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $34.3 million versus the consensus estimate of $52.8 million.
For earnings history and earnings-related data on Harrow Health (HROW) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Anthropic plans IPO potentially exceeding SpaceX's $86B record - Bloomberg
- Advance Auto Parts falls on revenue miss, weak guidance
- Harrow study shows Iheezo cuts discomfort after eye injections
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
